Strides Pharma Science Limited has informed the Exchange about press release dated 30-May-2022 titled Strides receives USFDA approval for Ibuprofen Oral Suspension
Press Release May 30 2022
Filed with NSE ·
6ix hasn’t read this filing yet.
Strides Pharma Science Ltd on 6ix
Earlier from Strides Pharma Science
- Press Release May 15 2022
- Press Release Mar 21 2022
- Press Release Mar 17 2022
- Newspaper Advertisements
- Extra Ordinary Meeting
Later from Strides Pharma Science
- Press Release Jun 10 2022
- Press Release Jun 16 2022
- Press Release Jun 24 2022
- Press Release Aug 03 2022
- Press Release Aug 08 2022
Follow Strides Pharma Science into a list and get an email when it puts out news.
Follow Strides Pharma Science